What is the recommended dosing and indication for albumin (human albumin) administration?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 29, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Recommended Dosing and Indications for Human Albumin Administration

Human albumin should be administered at 6-8 g/L of ascites fluid removed for large-volume paracentesis (>5L) and at 1.5 g/kg on day 1 followed by 1 g/kg on day 3 for spontaneous bacterial peritonitis in cirrhotic patients. 1

Primary Indications for Albumin Administration

Large-Volume Paracentesis

  • Recommended dose: 6-8 g per liter of ascites fluid removed for paracentesis >5 liters 1
  • For patients with low-severity cirrhosis, a half dose (4 g/L) may be effective and safe 1
  • Should be administered slowly to prevent cardiac overload, especially in patients with preexisting cardiomyopathy 1
  • Limit ascites removal to less than 8 liters during a single paracentesis procedure to reduce paracentesis-induced circulatory dysfunction (PICD) risk 1
  • Reduces risk of PICD by 61% compared to alternative treatments 1
  • Reduces hyponatremia risk by 42% and mortality by 36% 1

Spontaneous Bacterial Peritonitis (SBP)

  • Recommended dose: 1.5 g/kg on day 1 and 1 g/kg on day 3 in combination with antibiotics 1
  • Reduces incidence of renal impairment (10% vs 33%) and death (22% vs 41%) compared to antibiotics alone 1
  • May be most beneficial for high-risk patients (serum bilirubin >4 mg/dL or serum creatinine >1 mg/dL) 1
  • Careful assessment of volume status, cardiovascular status, and kidney function is advised before administration 1

Hepatorenal Syndrome

  • Used in combination with vasoconstrictors (typically terlipressin) 1, 2
  • Recommended dose: 1 g/kg before initiating vasoconstrictor treatment, then 20-40 g/day 1
  • Duration of treatment and hemodynamic objectives remain empirical 1

Secondary Indications

Hypovolemic Shock

  • Volume and speed of infusion should be adapted to individual patient response 3
  • Should not exceed the level of albumin found in normal individuals (about 2 g/kg body weight) in the absence of active bleeding 3

Burns

  • Used after 24 hours post-burn injury 3
  • Aim to maintain plasma albumin concentration at 2.5 ± 0.5 g/100 mL 3
  • Duration determined by protein loss from burned areas and in urine 3

Hypoproteinemia With or Without Edema

  • Usual daily dose: 50-75 g for adults and 25 g for children 3
  • Administration rate should not exceed 2 mL/minute to avoid circulatory embarrassment and pulmonary edema 3
  • Should be considered supportive rather than nutritional therapy 3

Other Indications

  • Cardiopulmonary bypass: Used in pump prime to achieve hematocrit of 20% and plasma albumin concentration of 2.5 g/100 mL 3
  • Acute liver failure: Supports colloid osmotic pressure and binds excess plasma bilirubin 3
  • Neonatal hemolytic disease: 1 g/kg body weight given about 1 hour prior to exchange transfusion 3
  • Sequestration of protein-rich fluids (acute peritonitis, pancreatitis, mediastinitis, extensive cellulitis) 3

Non-Recommended Uses

  • Not recommended for patients with cirrhosis and extraperitoneal infections 1
  • Not recommended for routine treatment of hypoalbuminemia in decompensated cirrhosis 1
  • Not recommended for nutritional purposes 4

Administration Considerations

  • Should always be administered intravenously 3
  • May be given undiluted or diluted in 0.9% Sodium Chloride or 5% Dextrose in Water 3
  • If sodium restriction is required, should only be administered undiluted or diluted in sodium-free carbohydrate solution 3
  • For hypoproteinemic patients, rate should not exceed 2 mL/minute 3
  • Parenteral products should be inspected visually for particulate matter and discoloration prior to administration 3

Cautions and Monitoring

  • Monitor for signs of fluid overload, especially in patients with preexisting cardiac conditions 1
  • Assess volume status, cardiovascular function, and kidney function before administration 1
  • Consider personalized dosing based on baseline creatinine, volume of ascites removed, and history of hypotensive symptoms 1
  • Be vigilant for pulmonary edema, especially when using higher doses for SBP 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Indications for Albumin Use

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Albumin: a comprehensive review and practical guideline for clinical use.

European journal of clinical pharmacology, 2024

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.